Opdualag

nivolumab and relatlimab-rmbw

Approval

ApplicationBLA 761234
Approval dateMar 18, 2022
Approval year2022
SponsorBristol Myers Squibb

FDA-approved use

To treat unresectable or metastatic melanoma

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Opdualag: